I'm Giddy Over This New Olive Oil Company, and 4 Other New Home Releases
Graza's Spanish-made extra-virgin olive oil has me squeezing the stuff on almost everything.
Stay updated with breaking news from Associate Staff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Graza's Spanish-made extra-virgin olive oil has me squeezing the stuff on almost everything.
If any former president had access to an operational time machine, it may have been former President Gerald Ford. But his foresight would not focus on the degradation of America’s international standing or the fiscal ramifications of stagflation and untethered federal spending. Rather, it would deal with how America would elect, or more precisely, promote the first female president. When Ford visited the Herbert Hoover Presidential Library and Museum in West Branch, Iowa, on Oct. 18, 1989 — approximately a decade after leaving office — he was given the special chance to share with the...
The content on this page is intended to healthcare professionals and equivalents. Bothell, Wash.—FUJIFILM Sonosite, Inc., the world leader in point-of-care ultrasound (POCUS) solutions, and the CHEST Foundation, the charitable foundation of the American College of Chest Physicians, announced two recipients of the CHEST Foundation’s Research Grant in Ultrasonography and COVID-19 today. The grants include $30,000 in support and FUJIFILM Sonosite’s newly launched Sonosite PX ultrasound system for the study of POCUS efficacy in diagnosing and treating COVID-19 patients in the intensive care...
AI Helps to Study Which Cancer Patients Might be Harmed by Immunotherapy Written by AZoRoboticsFeb 5 2021 At Case Western Reserve University, scientists have used artificial intelligence (AI) to analyze simple tissue scans and discovered biomarkers that could pinpoint to doctors those lung cancer patients who might actually suffer worse from immunotherapy. Image credit: Design_Cells/shutterstock.com To date, oncologists and scientists had classified these lung cancer patients into two wider categories—those who would benefit from immunotherapy, and those who would probably not. However, acc...